Draymond Green missed the final 20 minutes of the Golden State Warriors' 120-97 win over the Orlando Magic after going to locker room following a heated argument with coach Steve Kerr. The exchange ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Editor's note: Season 2 spoilers of "Landman" ahead! With Season 2 of "Landman" approaching its mid-point, viewers are given a candid insight into Tommy Norris (Billy Bob Thornton) and his childhood ...

This story was supported by the Pulitzer Center. The town hall in Akranes, on the west coast of Iceland, filled quickly as locals streamed in to the residents’ meeting. The mood was happy, positive, ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Any Lucia Lopez Belloza was deported to Honduras last week, documents show. A 19-year-old college student who was on her way to surprise her family for Thanksgiving break was detained at a Boston ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

The DOJ said his removal is "in the public interest." The Trump administration has moved to dissolve the ban on Kilmar Abrego Garcia's removal so that it can proceed with his deportation to Liberia.

Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...